New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
07:08 EDTRXIIRXi Pharmaceuticals granted US Notice of Allowance for technology platform
RXi Pharmaceuticals received the Notice of Allowance from the USPTO on its novel, self-delivering RNAi platform. The patent broadly covers both the composition and methods of use of RXi's self-delivering platform technology. The patent, once issued, will be scheduled to expire in 2029.
News For RXII From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
07:10 EDTRXIIRXi Pharmaceuticals signs exclusive global license for second Phase 2 compound
Subscribe for More Information
December 17, 2014
07:10 EDTRXIIRXi Pharmaceuticals begins Phase 2 study of scar revision surgery candidate
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use